- Rhino Federated Computing, headquartered in Boston, Massachusetts, specializes in federated computing solutions that connect siloed data sources, enabling secure analytics and AI applications across regulated industries such as healthcare and finance.
- In the past year, Rhino raised $11.33 million in a Series A - II funding round on January 27, 2026, bringing their total funding to $42.38 million across nine rounds.
- Key partnerships include collaboration with Eli Lilly for an AI drug discovery program and the Cancer AI Alliance to develop a collaborative AI platform for cancer research.
- Rhino's ideal buyers are organizations in healthcare and finance looking to leverage decentralized data for compliance and innovation, addressing challenges related to data privacy and security while accelerating time-to-value for data collaborations.
Rhino Federated Computing operates with a streamlined departmental structure, comprising two main departments: Executive with a headcount of 2 and Finance with 1 employee. This limited departmental mix reflects a focused organizational strategy, likely aimed at maintaining agility in decision-making and financial oversight. The absence of new hires and attrition over the last 12 months indicates stability within the workforce.
The company is headquartered in Boston, Massachusetts, with a total of three locations. The primary geographic distribution includes Irving, TX, with 1 employee, while the remaining 2 employees are categorized under 'Other' locations. This suggests a centralized operational model with minimal geographic dispersion, reinforcing a concentrated workforce strategy.
